8-K 1 form_8k.htm FORM 8K Q4 FINANCIAL RESULTS form_8k.htm
8-K 1 Form8-k.htm FORM 8-K Q4 Financial Results

 


SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 

 
DATE OF REPORT – March 11, 2008
 
(Date of Earliest Event Reported)
 
COLUMBIA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
 
Commission File No.  1-10352

 
Delaware
  
59-2758596
(State of Incorporation)
  
(I.R.S. Employer
Identification No.)
     
354 Eisenhower Parkway
Livingston, New Jersey
  
 
07039
(Address of principal
executive offices)
  
Zip Code

 
Registrant’s telephone number, including area code:  (973) 994-3999
 

 
 
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
Item 2.02                      Results of Operations and Financial Condition

 
On March 11, 2008, Columbia Laboratories, Inc. (the “Company”), issued a press release entitled, “Columbia Laboratories Reports Fourth Quarter and Year-End 2007 Financial Results.” A copy of the press release issued by the Company is furnished herewith as Exhibit 99.1.
 

 
The information contained in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this Current Report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.
 
Item 9.01                      Financial Statements and Exhibits
 
 (d)        Exhibits. 
 
 
99.1
Press Release dated March 11, 2008, entitled “Columbia Laboratories Reports Fourth Quarter and Year-End 2007 Financial Results.”
 

 
 
 

 
SIGNATURE
 

 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:  March 11, 2008
 

 
                                            COLUMBIA LABORATORIES, INC.
 
                                            By: /S/ James A. Meer
                                            James A. Meer
                                            Senior Vice President, Chief Financial Officer & Treasurer

 
 

 
 
Exhibit Index
 
Exhibit No.
Description
99.1
Press Release dated March 11, 2008, entitled “Columbia Laboratories Reports Fourth Quarter and Year-End 2007 Financial Results.”